Psychedelic Spotlight Videos

Dr. Matthew Johnson: Psychedelics, Consciousness, DMT Experiences & The CIA

In this much anticipated Psychedelic Spotlight podcast, we get to see James from The Psychedelic Investor and Dr. Matthew Johnson of Johns Hopkins University discuss a broad range of topics surrounding psychedelics and their effectiveness as treatments for ailments like tobacco addiction and PTSD. Timestamps: 0:00 – Intro 1:10 – Dr. Johnson’s latest updates on […]

Numinus Wellness CEO Discusses MAPS Partnership & How Psychedelics Will Change Society

In this episode James, from The Psychedelic Investor, sits down with Numinus Wellness’ (OTC: NUMIF, TSX.V: NUMI) CEO Payton Nyquvest for the Psychedelic Spotlight Podcast. Numinus is a Psychedelic Medicines company focused on scaling up psychedelic therapy. Perhaps most exciting is their partnership with MAPS, where the two companies are working together to provide MDMA […]

Interview with Bright Minds Biosciences’ CEO Ian McDonald

In today’s episode of the Psychedelic Spotlight podcast, the Psychedelic Investor, James Hallifax interviews Ian McDonald, CEO and Director of Bright Minds Biosciences. For any investors out there, you can find Bright Minds Biosciences trading on the Canadian Securities Exchange under the symbol $DRUG and on the American OTC market under the symbol $BMBIF. In […]

Why the Psychedelic Drug Market is Experiencing Major Growth

David Flores, CEO of Global Trac Solutions (PSYC), joins Cheddar to discuss the company’s digital media platform ‘Psychedelic Spotlight’, factors contributing to a more open-minded approach to psychedelics among the scientific and medical communities, and why investors are seeing the psychedelic market as an opportunity for growth. #business #psychedelics #investments source